0001209191-21-030121.txt : 20210504 0001209191-21-030121.hdr.sgml : 20210504 20210504195141 ACCESSION NUMBER: 0001209191-21-030121 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201210 FILED AS OF DATE: 20210504 DATE AS OF CHANGE: 20210504 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TANG KEVIN C CENTRAL INDEX KEY: 0001178579 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36282 FILM NUMBER: 21890618 MAIL ADDRESS: STREET 1: 4747 EXECUTIVE DRIVE STREET 2: SUITE 210 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO CENTRAL INDEX KEY: 0000920465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330361285 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4747 EXECUTIVE DRIVE, SUITE 240 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-207-4264 MAIL ADDRESS: STREET 1: 4747 EXECUTIVE DRIVE, SUITE 240 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-12-10 0 0000920465 LA JOLLA PHARMACEUTICAL CO LJPC 0001178579 TANG KEVIN C 4747 EXECUTIVE DRIVE, SUITE 210 SAN DIEGO CA 92121 1 0 1 0 Stock Option (Right to Buy) 4.53 2020-12-10 4 A 0 30000 0.00 A 2030-12-10 Common Stock 30000 30000 D The late filing of the reported transaction is due to an inadvertent administrative error. The stock options vest and become exercisable on December 10, 2021, subject to the Reporting Person's continued service to the Issuer through such date. /s/ Kevin Tang 2021-05-04